Urine biochemical markers of early renal dysfunction are associated with iron overload in β-thalassaemia

被引:66
作者
Koliakos, G
Papachristou, F
Koussi, A
Perifanis, V
Tsatra, I
Souliou, E
Athanasiou, M
机构
[1] Aristotle Univ Thessaloniki, Dept Biol Chem, Sch Med, Thessaloniki, Greece
[2] Aristotle Univ Thessaloniki, Thalassemia Unit Hippocrat Gen Hosp, Dept Pediat 1, Sch Med, Thessaloniki, Greece
[3] Aristotle Univ Thessaloniki, Thalassemia Unit Hippocrat Gen Hosp, Prop Dept Med 2, Sch Med, Thessaloniki, Greece
[4] Aristotle Univ Thessaloniki, Dept Microbiol, Sch Med, Thessaloniki, Greece
来源
CLINICAL AND LABORATORY HAEMATOLOGY | 2003年 / 25卷 / 02期
关键词
beta-thalassemia; iron overload; tubular dysfunction; urine makers; desferioxamine;
D O I
10.1046/j.1365-2257.2003.00507.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Renal dysfunction in thalassemia patients can be attributed to chronic anemia, and iron overload as well as to desferioxamine (DFO) toxicity. We analyzed the urine of 91 well-maintained homozygous beta-thalassemia patients, with no evidence of renal disease, for early evidence of kidney dysfunction by means of electrophoresis and quantitative biochemical tests. Measurement of liver magnetic resonance imaging (MRI) T2 values and serum ferritin concentration was used to estimate iron overload. In 55 of the 91 patients, urine analysis indicated signs of tubular dysfunction. The urine concentration of albumin and beta 2-microglobulin, as well as the activity of n-acetyl-beta-d-glucosaminidase (NAG), correlated positively with serum ferritin concentration and liver iron deposition, as detected by MRI T2 values. This suggested that the cause of renal dysfunction in homozygous beta-thalassemia is iron overload. On the other hand, the same urine markers did not correlate with age, indicating that chronic anemia or desferrioxamine (DFO) treatment are not related to renal dysfunction in thalassemia.
引用
收藏
页码:105 / 109
页数:5
相关论文
共 24 条
[1]   Renal function in pediatric patients with β-thalassemia major [J].
Aldudak, B ;
Bayazit, AK ;
Noyan, A ;
Özel, A ;
Anarat, A ;
Sasmaz, I ;
Kilinç, Y ;
Gali, E ;
Anarat, R ;
Dikmen, N .
PEDIATRIC NEPHROLOGY, 2000, 15 (1-2) :109-112
[2]   SODIUM DODECYL-SULFATE ELECTROPHORESIS OF URINARY PROTEINS [J].
BIANCHIBOSISIO, A ;
DAGROSA, E ;
GABOARDI, F ;
GIANAZZA, E ;
RIGHETTI, PG .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1991, 569 (1-2) :243-260
[3]   ARTERIAL BLOOD-PRESSURE SERUM-LIPIDS AND CARDIOVASCULAR COMPLICATIONS IN FAMILIES OF HYPERTENSIVE CHILDREN [J].
CASSIMOS, C ;
AIVAZIS, V ;
KARAMPERIS, S ;
VARLAMIS, G ;
KATSOUYANNOPOULOS, V .
ACTA PAEDIATRICA SCANDINAVICA, 1982, 71 (02) :235-238
[4]   EARLY DETECTION OF NEPHROTOXIC EFFECTS IN THALASSEMIC PATIENTS RECEIVING DESFERRIOXAMINE THERAPY [J].
CIANCIULLI, P ;
SOLLECITO, D ;
SORRENTINO, F ;
FORTE, L ;
GILARDI, E ;
MASSA, A ;
PAPA, G ;
CARTA, S .
KIDNEY INTERNATIONAL, 1994, 46 (02) :467-470
[5]   Iron overload and kidney lysosomes [J].
Dimitriou, E ;
Kairis, M ;
Sarafidou, J ;
Michelakakis, H .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2000, 1501 (2-3) :138-148
[6]   SIMPLIFIED METHOD FOR SILVER STAINING OF PROTEINS IN POLYACRYLAMIDE GELS AND THE MECHANISM OF SILVER STAINING [J].
HEUKESHOVEN, J ;
DERNICK, R .
ELECTROPHORESIS, 1985, 6 (03) :103-112
[7]   PREVALENCE OF BETA-O AND BETA-+ THALASSEMIA GENES IN GREEK CHILDREN WITH HOMOZYGOUS BETA-THALASSEMIA [J].
KATTAMIS, C ;
KARAMBULA, K ;
METAXOTOUMAVROMATI, A ;
LADIS, V ;
CONSTANTOPOULOS, A .
HEMOGLOBIN, 1978, 2 (01) :29-46
[8]   Electrophoretic analysis of urinary proteins in diabetic adolescents [J].
Koliakos, G ;
Papachristou, F ;
Papadopoulou, M ;
Trachana, V ;
Gaitatzi, M ;
Sotiriou, I .
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2001, 15 (04) :178-183
[9]  
KOREN G, 1991, INT J HEMATOL, V54, P371
[10]   ACUTE CHANGES IN RENAL-FUNCTION ASSOCIATED WITH DEFEROXAMINE THERAPY [J].
KOREN, G ;
BENTUR, Y ;
STRONG, D ;
HARVEY, E ;
KLEIN, J ;
BAUMAL, R ;
SPIELBERG, SP ;
FREEDMAN, MH .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1989, 143 (09) :1077-1080